Renal Effects of Melatonin Trial in Chronic Kidney Disease

Completed · Not applicable · Has a placebo group

Conditions studied: Chronic Kidney Diseases

In brief

This will be a prospective, double blinded, randomized, controlled pilot study to determine if there is any correlation between melatonin administration and proteinuria.

Key facts

Study ID

NCT04336566

Run by

University of Oklahoma

People needed

31

Starts

2019-07-01

Expected to finish

2020-05-13

Last updated by the study team

2020-08-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Are between ages 18 and up with chronic kidney disease (CKD) I-III (stage 3 kidney disease, kidney dysfunction)
• Random urine microalbumin of 30 mcg or greater (protein in the urine)
• Have ability to complete a sleep survey
• Currently not on melatonin therapy.

You may not qualify if…

• End Stage Renal Disease
• CKD Stage IV (stage 4 with severe kidney dysfunction)
• Severe liver disease
• Chronic dialysis therapy

Where it is running

• University of Oklahoma School of Community Medicine — Tulsa, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.